A transcription factor of lipid synthesis, sterol regulatory element-binding protein (SREBP)-1a causes G(1) cell-cycle arrest after accumulation of cyclin-dependent kinase (cdk) inhibitors - PubMed (original) (raw)
. 2007 Sep;274(17):4440-52.
doi: 10.1111/j.1742-4658.2007.05973.x. Epub 2007 Jul 27.
Affiliations
- PMID: 17662109
- DOI: 10.1111/j.1742-4658.2007.05973.x
Free article
A transcription factor of lipid synthesis, sterol regulatory element-binding protein (SREBP)-1a causes G(1) cell-cycle arrest after accumulation of cyclin-dependent kinase (cdk) inhibitors
Masanori Nakakuki et al. FEBS J. 2007 Sep.
Free article
Abstract
Sterol regulatory element-binding protein (SREBP)-1a is a unique membrane-bound transcription factor highly expressed in actively growing cells and involved in the biosynthesis of cholesterol, fatty acids, and phospholipids. Because mammalian cells need to synthesize membrane lipids for cell replication, the functional relevance of SREBP-1a in cell proliferation has been considered a biological adaptation. However, the effect of this potent lipid-synthesis activator on cell growth has never been explored. Here, we show that induction of nuclear SREBP-1a, but not SREBP-2, completely inhibited cell growth in inducible Chinese hamster ovary (CHO) cell lines. Growth inhibition occurred through G(1) cell-cycle arrest, which is observed in various cell types with transient expression of nuclear SREBP-1a. SREBP-1a caused the accumulation of cyclin-dependent kinase (cdk) inhibitors such as p27, p21, and p16, leading to reduced cdk2 and cdk4 activities and hypophosphorylation of Rb protein. In contrast to transactivation of p21, SREBP-1a activated p27 by enhancing stabilization of the protein through inhibition of SKP2 and KPC1. In vivo, SREBP-1a-expressing livers of transgenic mice exhibited impaired regeneration after partial hepatectomy. SREBP-1-null mouse embryonic fibroblasts had a higher cell proliferation rate than wild-type cells. The unexpected cell growth-inhibitory role of SREBP-1a provides a new paradigm to link lipid synthesis and cell growth.
Similar articles
- Lipid synthetic transcription factor SREBP-1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor.
Inoue N, Shimano H, Nakakuki M, Matsuzaka T, Nakagawa Y, Yamamoto T, Sato R, Takahashi A, Sone H, Yahagi N, Suzuki H, Toyoshima H, Yamada N. Inoue N, et al. Mol Cell Biol. 2005 Oct;25(20):8938-47. doi: 10.1128/MCB.25.20.8938-8947.2005. Mol Cell Biol. 2005. PMID: 16199872 Free PMC article. - Reciprocal regulation of the human sterol regulatory element binding protein (SREBP)-1a promoter by Sp1 and EGR-1 transcription factors.
Fernández-Alvarez A, Tur G, López-Rodas G, Casado M. Fernández-Alvarez A, et al. FEBS Lett. 2008 Jan 23;582(2):177-84. doi: 10.1016/j.febslet.2007.11.083. Epub 2007 Dec 7. FEBS Lett. 2008. PMID: 18068676 - Effect of sterol regulatory element binding protein-1a on the mitochondrial protein pattern in human liver cells detected by 2D-DIGE.
Lehr S, Kotzka J, Avci H, Knebel B, Muller S, Hanisch FG, Jacob S, Haak C, Susanto F, Muller-Wieland D. Lehr S, et al. Biochemistry. 2005 Apr 5;44(13):5117-28. doi: 10.1021/bi0479656. Biochemistry. 2005. PMID: 15794649 - SREBP transcription factors: master regulators of lipid homeostasis.
Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F. Eberlé D, et al. Biochimie. 2004 Nov;86(11):839-48. doi: 10.1016/j.biochi.2004.09.018. Biochimie. 2004. PMID: 15589694 Review. - De novo cholesterol synthesis at the crossroads of adaptive response to extracellular stress through SREBP.
Robichon C, Dugail I. Robichon C, et al. Biochimie. 2007 Feb;89(2):260-4. doi: 10.1016/j.biochi.2006.09.015. Epub 2006 Oct 12. Biochimie. 2007. PMID: 17059860 Review.
Cited by
- Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.
Zhao Q, Lin X, Wang G. Zhao Q, et al. Front Oncol. 2022 Jul 14;12:952371. doi: 10.3389/fonc.2022.952371. eCollection 2022. Front Oncol. 2022. PMID: 35912181 Free PMC article. Review. - SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.
Shimano H, Sato R. Shimano H, et al. Nat Rev Endocrinol. 2017 Dec;13(12):710-730. doi: 10.1038/nrendo.2017.91. Epub 2017 Aug 29. Nat Rev Endocrinol. 2017. PMID: 28849786 Review. - Targeting SREBP-1-driven lipid metabolism to treat cancer.
Guo D, Bell EH, Mischel P, Chakravarti A. Guo D, et al. Curr Pharm Des. 2014;20(15):2619-26. doi: 10.2174/13816128113199990486. Curr Pharm Des. 2014. PMID: 23859617 Free PMC article. Review. - LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells.
Li Y, Jing C, Tang X, Chen Y, Han X, Zhu Y. Li Y, et al. Endocrine. 2016 Sep;53(3):689-700. doi: 10.1007/s12020-016-0915-8. Epub 2016 Apr 12. Endocrine. 2016. PMID: 27071658 - Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif.
Seo YK, Chong HK, Infante AM, Im SS, Xie X, Osborne TF. Seo YK, et al. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13765-9. doi: 10.1073/pnas.0904246106. Epub 2009 Aug 4. Proc Natl Acad Sci U S A. 2009. PMID: 19666523 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous